These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Effects of statin intervention on mild coronary plaque progression assessed by serial coronary CT angiography]. Li ZN; Hou ZH; Liu K; Wang ZQ; Yin WH; Gao Y; Xu HY; Jiang SL; Lyu B Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Jun; 44(6):508-12. PubMed ID: 27346264 [TBL] [Abstract][Full Text] [Related]
23. Rationale, design features, and baseline characteristics: The Heart Institute of Japan-PRoper level of lipid lOwering with Pitavastatin and Ezetimibe in acute coRonary syndrome (HIJ-PROPER). Kawada-Watanabe E; Ogawa H; Koyanagi R; Arashi H; Yamaguchi J; Matsui K; Hagiwara N J Cardiol; 2017 Mar; 69(3):536-541. PubMed ID: 27349705 [TBL] [Abstract][Full Text] [Related]
24. Remodeling pattern is related to the degree of coronary plaque regression induced by pitavastatin: a sub-analysis of the TOGETHAR trial with intravascular ultrasound and coronary angioscopy. Takayama T; Hiro T; Ueda Y; Saito S; Kodama K; Komatsu S; Hirayama A Heart Vessels; 2015 Mar; 30(2):169-76. PubMed ID: 24463843 [TBL] [Abstract][Full Text] [Related]
25. Stabilization of atherosclerotic plaque by pitavastatin in Watanabe heritable hyperlipidemic rabbits: A serial tissue-characterizing intravascular ultrasound study. Haruta H; Hiro T; Mitsumata M; Takayama T; Sudo M; Li Y; Takahashi R; Taniguchi Y; Shiomi M; Hirayama A J Cardiol; 2016 Feb; 67(2):205-11. PubMed ID: 26194868 [TBL] [Abstract][Full Text] [Related]
26. Changes of coronary plaque composition correlate with C-reactive protein levels in patients with ST-elevation myocardial infarction following high-intensity statin therapy. Koskinas KC; Zaugg S; Yamaji K; García-García HM; Taniwaki M; Klingenberg R; Moschovitis A; Lüscher TF; van Tits LJ; Matter CM; Windecker S; Räber L Atherosclerosis; 2016 Apr; 247():154-60. PubMed ID: 26921743 [TBL] [Abstract][Full Text] [Related]
27. Relation between progression and regression of atherosclerotic left main coronary artery disease and serum cholesterol levels as assessed with serial long-term (> or =12 months) follow-up intravascular ultrasound. von Birgelen C; Hartmann M; Mintz GS; Baumgart D; Schmermund A; Erbel R Circulation; 2003 Dec; 108(22):2757-62. PubMed ID: 14623804 [TBL] [Abstract][Full Text] [Related]
28. Plaque volume and plaque risk profile in diabetic vs. non-diabetic patients undergoing lipid-lowering therapy: a study based on 3D intravascular ultrasound and virtual histology. Kovarnik T; Chen Z; Mintz GS; Wahle A; Bayerova K; Kral A; Chval M; Kopriva K; Lopez J; Sonka M; Linhart A Cardiovasc Diabetol; 2017 Dec; 16(1):156. PubMed ID: 29212544 [TBL] [Abstract][Full Text] [Related]
29. Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. Callister TQ; Raggi P; Cooil B; Lippolis NJ; Russo DJ N Engl J Med; 1998 Dec; 339(27):1972-8. PubMed ID: 9869668 [TBL] [Abstract][Full Text] [Related]
30. Comparison of the lipid-lowering effects of pitavastatin 4 mg versus pravastatin 40 mg in adults with primary hyperlipidemia or mixed (combined) dyslipidemia: a Phase IV, prospective, US, multicenter, randomized, double-blind, superiority trial. Sponseller CA; Morgan RE; Kryzhanovski VA; Campbell SE; Davidson MH Clin Ther; 2014 Aug; 36(8):1211-22. PubMed ID: 24998014 [TBL] [Abstract][Full Text] [Related]
31. Treatment with statin on atheroma regression evaluated by intravascular ultrasound with Virtual Histology (TRUTH Study): rationale and design. Nozue T; Yamamoto S; Tohyama S; Umezawa S; Kunishima T; Sato A; Miyake S; Takeyama Y; Morino Y; Yamauchi T; Muramatsu T; Hibi K; Sozu T; Michishita I; Circ J; 2009 Feb; 73(2):352-5. PubMed ID: 19110505 [TBL] [Abstract][Full Text] [Related]
32. Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention: The Multicenter Randomized Controlled PRECISE-IVUS Trial. Tsujita K; Sugiyama S; Sumida H; Shimomura H; Yamashita T; Yamanaga K; Komura N; Sakamoto K; Oka H; Nakao K; Nakamura S; Ishihara M; Matsui K; Sakaino N; Nakamura N; Yamamoto N; Koide S; Matsumura T; Fujimoto K; Tsunoda R; Morikami Y; Matsuyama K; Oshima S; Kaikita K; Hokimoto S; Ogawa H; J Am Coll Cardiol; 2015 Aug; 66(5):495-507. PubMed ID: 26227186 [TBL] [Abstract][Full Text] [Related]
33. Plasma low-density lipoprotein reduction and structural effects on coronary atherosclerotic plaques by atorvastatin as clinically assessed with intravascular ultrasound radio-frequency signal analysis: a randomized prospective study. Yokoyama M; Komiyama N; Courtney BK; Nakayama T; Namikawa S; Kuriyama N; Koizumi T; Nameki M; Fitzgerald PJ; Komuro I Am Heart J; 2005 Aug; 150(2):287. PubMed ID: 16086932 [TBL] [Abstract][Full Text] [Related]
34. Rationale of decreasing low-density lipoprotein cholesterol below 70 mg/dL in patients with coronary artery disease: A retrospective virtual histology-intravascular ultrasound study. Seo YH; Seo DJ; Song IG; Kim KH; Kwon TG; Bae JH Cardiol J; 2018; 25(6):674-682. PubMed ID: 29341060 [TBL] [Abstract][Full Text] [Related]
35. Effects of lipid-lowering therapy on coronary artery remodeling. Schartl M; Bocksch W; Fateh-Moghadam S Coron Artery Dis; 2004 Feb; 15(1):45-51. PubMed ID: 15201620 [TBL] [Abstract][Full Text] [Related]
36. Coronary plaque progression of non-culprit lesions after culprit percutaneous coronary intervention in patients with moderate to advanced chronic kidney disease: intravascular ultrasound and integrated backscatter intravascular ultrasound study. Kashiyama K; Sonoda S; Muraoka Y; Suzuki Y; Kamezaki F; Tsuda Y; Araki M; Tamura M; Takeuchi M; Abe H; Okazaki M; Fujino Y; Otsuji Y Int J Cardiovasc Imaging; 2015 Jun; 31(5):935-45. PubMed ID: 25724567 [TBL] [Abstract][Full Text] [Related]
37. Effect of atherosclerotic regression on total luminal size of coronary arteries as determined by intravascular ultrasound. Tardif JC; Grégoire J; L'Allier PL; Ibrahim R; Lavoie MA; LeMay M; Cohen E; Levesque S; Keller PF; Heinonen T; Guertin MC Am J Cardiol; 2006 Jul; 98(1):23-7. PubMed ID: 16784914 [TBL] [Abstract][Full Text] [Related]
38. Clinical significance of non-culprit plaque regression following acute coronary syndrome: A serial intravascular ultrasound study. Endo H; Dohi T; Miyauchi K; Kuramitsu S; Kato Y; Okai I; Yokoyama M; Yokoyama T; Ando K; Okazaki S; Shimada K; Suwa S; Daida H J Cardiol; 2019 Aug; 74(2):102-108. PubMed ID: 30737184 [TBL] [Abstract][Full Text] [Related]
39. Comparison of effects of rosuvastatin and atorvastatin on plaque regression in Korean patients with untreated intermediate coronary stenosis. Hong YJ; Jeong MH; Hachinohe D; Ahmed K; Choi YH; Cho SH; Hwang SH; Ko JS; Lee MG; Park KH; Sim DS; Yoon NS; Yoon HJ; Kim KH; Park HW; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC Circ J; 2011; 75(2):398-406. PubMed ID: 21157106 [TBL] [Abstract][Full Text] [Related]
40. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. Nissen SE; Nicholls SJ; Sipahi I; Libby P; Raichlen JS; Ballantyne CM; Davignon J; Erbel R; Fruchart JC; Tardif JC; Schoenhagen P; Crowe T; Cain V; Wolski K; Goormastic M; Tuzcu EM; JAMA; 2006 Apr; 295(13):1556-65. PubMed ID: 16533939 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]